Researchers identify novel cell type that leads to aggressive leukemia

March 7, 2014 by Josh Barney, University of Virginia
Renin progenitors in the bone marrow with a lymphocyte pedigree (Brenin cells, shown in green) give rise to B-cell leukemia when the Notch pathway effector RBP-J is deleted. Credit: Maria Luisa S. Sequeira Lopez

Researchers at the University of Virginia School of Medicine have discovered a specific type of immune cell in the bone marrow of mice responsible for an aggressive, poorly understood form of leukemia.

The type of examined in the study proved particularly hardy and resourceful. After the cancer killed a mouse with the responsible mutation, the researchers placed the in a lab dish, where they continued to survive and even thrive.

"People have been trying to grow in culture, even from patients, and they require other factors to survive. But not these," said Dr. Maria Luisa S. Sequeira-Lopez, a researcher in the Division of Pediatric Nephrology.

Her co-researcher, Dr. Ariel Gomez, also of the Division of Pediatric Nephrology, marveled at the cells' ability to tolerate even the least hospitable conditions. "These are extremely aggressive in that they have developed a system to grow and survive no matter what," he said. "They have immortalized themselves."

The research provides important insight into B-cell leukemia, the causes of which are poorly understood, and could lead to new and better treatments.

In this case, the loss of a key cellular signaling molecule through mutation appears to trigger the development of the leukemia. More specifically, the loss of the signaling molecule caused a logjam in the production process of B cells, a type of white blood cell. The mutated cells then become cancerous.

The type of cell affected is a renin progenitor. Renin cells, which are also present in the kidney, have traditionally been associated with the control of blood pressure and fluid balance in the body. However, U.Va. investigators found that there are renin progenitors in the as well.

The role of bone marrow renin cells in the development of leukemia had been unknown, but the U.Va. researchers were able to determine that the leukemia originated in a special type of white blood cell, a B lymphocyte that expresses renin – a cell the group has dubbed "Brenin-cells." The researchers then went on to discover and describe the genetic and epigenetic events that lead to the leukemia.

Conventional wisdom is that leukemia arises when a genetic event occurs in a susceptible cell. Over the last decade, much knowledge has been gained regarding the genetic events that drive leukemia; the exact cell of origin, however, remains largely unknown. This study suggests that there may be subsets of cells at increased risk of developing leukemia.

The discovery means the researchers have many exciting avenues to explore. U.Va.  pediatrician Dr. Brian C. Belyea, the lead author of the paper outlining the findings, is investigating whether the findings will hold true in humans.

"We would now like to see if this is a relevant model of human disease," he said. "Our long-term goal is to identify cells at increased risk for leukemia in humans and ultimately develop strategies to monitor and eliminate these ."

Explore further: Rare form of leukemia found to originate in stem cells

More information: "Identification of renin progenitors in the mouse bone marrow that give rise to B-cell leukaemia." Brian C. Belyea, et al. Nature Communications 5, Article number: 3273 DOI: 10.1038/ncomms4273. Received 10 August 2013 Accepted 16 January 2014 Published 18 February 2014

Related Stories

Rare form of leukemia found to originate in stem cells

February 13, 2014
(Medical Xpress)—An international team of researchers working out of the University of Toronto has found that one type of rare leukemia appears to get its start in stem cells. In their paper published in the journal Nature, ...

Common mutation is culprit in acute leukemia relapse

March 6, 2014
Harvard stem cell scientists have identified a mutation in human cases of acute lymphoblastic leukemia that likely drives relapse. The research, published in Cancer Cell, could translate into improved patient care strategies ...

Researchers discover how a mutated protein outwits evolution and fuels leukemia

June 20, 2013
Scientists have discovered the survival secret to a genetic mutation that stokes leukemia cells, solving an evolutionary riddle and paving the way to a highly targeted therapy for leukemia. In a paper published today in Cell, ...

Cancer researchers discover pre-leukemic stem cell at root of AML, relapse

February 12, 2014
Feb. 12, 2014) – Cancer researchers led by stem cell scientist Dr. John Dick have discovered a pre-leukemic stem cell that may be the first step in initiating disease and also the culprit that evades therapy and triggers ...

FDA approves Pfizer drug for rare blood cancer

September 4, 2012
Pfizer Inc. says the Food and Drug Administration on Tuesday approved its new drug to treat a rare form of blood and bone marrow cancer.

A promising new approach for treating leukemia discovered

February 13, 2014
A group of researchers at the Institute for Research in Immunology and Cancer (IRIC) of Université de Montréal discovered a promising new approach to treating leukemia by disarming a gene that is responsible for tumor progression. ...

Recommended for you

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.